ALVO Alvotech

Price (delayed)

$5.38

Market cap

$1.92B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$3.23B

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 34

Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in ...

Highlights
ALVO's gross margin is up by 13% year-on-year
ALVO's quick ratio is down by 39% year-on-year but it is up by 33% since the previous quarter
The company's equity rose by 32% QoQ but it fell by 10% YoY
ALVO's net income has dropped by 122% since the previous quarter
The EPS has dropped by 114% since the previous quarter

Key stats

What are the main financial stats of ALVO

ALVO stock price

How has the Alvotech stock price performed over time
Intraday
-2.18%
1 week
-12.38%
1 month
1.7%
1 year
-32.5%
YTD
4.87%
QTD
-7.24%

Financial performance

How have Alvotech's revenue and profit performed over time
Revenue
$494.61M
Gross profit
$300.04M
Operating income
$47.54M
Net income
-$179.59M
Gross margin
60.7%
Net margin
-36.3%
ALVO's net margin has plunged by 152% from the previous quarter
ALVO's net income has dropped by 122% since the previous quarter
ALVO's operating income is down by 39% since the previous quarter and by 13% year-on-year
ALVO's operating margin is down by 30% since the previous quarter

Price vs fundamentals

How does ALVO's price correlate with its fundamentals

Growth

What is Alvotech's growth rate over time

Valuation

What is Alvotech stock price valuation
P/E
N/A
P/B
N/A
P/S
3.4
EV/EBIT
25.49
EV/EBITDA
19.22
EV/Sales
6.53
The EPS has dropped by 114% since the previous quarter
The company's equity rose by 32% QoQ but it fell by 10% YoY
The stock's price to sales (P/S) is 78% less than its 5-year quarterly average of 15.3 but 21% more than its last 4 quarters average of 2.8
ALVO's revenue is down by 12% year-on-year and by 12% since the previous quarter

Efficiency

How efficient is Alvotech business performance
The ROA has dropped by 114% since the previous quarter
The company's return on invested capital fell by 37% QoQ and by 13% YoY
The ROS is down by 27% since the previous quarter but it is up by 9% year-on-year

Dividends

What is ALVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALVO.

Financial health

How did Alvotech financials performed over time
The total assets is 11% smaller than the total liabilities
ALVO's quick ratio is down by 39% year-on-year but it is up by 33% since the previous quarter
ALVO's total liabilities is up by 14% year-on-year and by 4.4% since the previous quarter
ALVO's debt to equity is down by 47% since the previous quarter and by 3.6% year-on-year
The company's equity rose by 32% QoQ but it fell by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.